Escape from Tumor Dormancy Following Gene- or Viro-Therapies Is Mediated by Acquisition of a Phenotype in Which Innate Immune Surveillance Actively Drives Tumor Cell Recurrence

Kottke, T, Rommelfanger, D, Shim, KG et al. (8 more authors) (2016) Escape from Tumor Dormancy Following Gene- or Viro-Therapies Is Mediated by Acquisition of a Phenotype in Which Innate Immune Surveillance Actively Drives Tumor Cell Recurrence. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S296-S296.

Metadata

Authors/Creators:
  • Kottke, T
  • Rommelfanger, D
  • Shim, KG
  • Pulido, J
  • Thompson, J
  • Rajani, K
  • Bobr, O
  • Selby, P
  • Ilett, E
  • Melcher, A
  • Vile, R
Copyright, Publisher and Additional Information: © 2016, Author(s). This is an author produced version of a paper published in Molecular Therapy. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: May 2016
  • Accepted: 19 February 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Oncology and Cancer Research - Labs (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Jul 2016 10:48
Last Modified: 01 Nov 2016 22:05
Status: Published
Publisher: Nature Publishing Group
Related URLs:

Share / Export